UNSPSC 51282524: Cefalexin sodium

This classification denotes a cephalosporin antibiotic with the molecular structure C16H16N3O4S.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F78YJG0WXK chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-phenylacetyl)amino)-3-methyl-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as cefalexin sodium, which bears US NIH Compound Identifier 27447.

European Medicines Agency schedules Cefalexin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13273MIG. Most nations, for tariff and trade purposes, schedule cefalexin sodium under HS 29419000. SMILES: CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3CCCCC3)N)SC1)C(=O)[O-].[NA+].

UNSPSC 51282524 Cefalexin sodium is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local contract opportunities posted under this code show little alignment with cefalexin procurement. Instead, the tagged opportunities involve naloxone (an opioid-overdose reversal medication) and safe drug deactivation systems, as well as other antibiotics such as doxycycline and ciprofloxacin, indicating potential misclassification or cross-tagging within state and local procurement systems. State and local health departments, counties, and special-purpose health districts use pharmaceutical codes in this family to procure specific medications through piggyback agreements with established consortiums such as MMCAP Infuse, cooperative purchasing vehicles, and competitive sealed-bid processes. Vendors supplying under this code must meet standard pharmaceutical supplier requirements, including drug-free workplace certification, E-Verify employment verification, appropriate insurance coverage (workers' compensation, commercial general liability, professional liability), and compliance with federal regulations when FEMA or other federal funding is involved.

The Illinois Department of Public Health and Seminole County, Florida represent the recent issuing bodies. The Illinois award—a piggyback pharmaceutical warehouse order through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, with a total contract value of $2,999,999.11 over 36 months including renewals—involved doxycycline and ciprofloxacin tablets under an Invitation for Bid process. Seminole County's solicitation (IFB 60459723LAS, posted June 30, 2026, response deadline July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the procurement included E-Verify and drug-free workplace compliance requirements and potential FEMA funding with associated federal compliance obligations. Geographic activity appears concentrated in Florida and Illinois in the recent record. The code shows limited decision-relevant recent activity directly tied to cefalexin procurement itself; opportunities tagged under it diverge significantly from the commodity's nominal scope.